Anti-Tumor Efficacy of Photodynamic Therapy of Solid Tumors in Laboratory Animals with Guanidine and Biguanidine Derivatives of Chlorine e6

We evaluated antitumor efficacy of photodynamic therapy of murine Ehrlich carcinoma and rat sarcoma M-1 with new photosensitizers 131-N-(4-aminobutyl)amydo chlorine e6 (1), 132-(5-guanidylbutanamido)-chlorine e6 (2), and 132-(5-biguanidylbutanamido)-chlorine e6 (3). The inhibiting effect of the photodynamic therapy was evaluated by the following parameters: tumor growth inhibition, complete regression of the tumors, and absolute growth rate of the tumor nodes in animals with the continued neoplasia growth. The criterion of cure was the absence of tumors up to 90 days after the therapy. It is shown that the studied photosensitizers have high antitumor activity in the photodynamic therapy of the Ehrlich carcinoma and sarcoma M-1.

Authors
Ivanov S.A. 1 , Kaprin A.D. 1 , Abramova O.B. , Kozlovtseva E.A. , Drozhzhina V.V. , Ostroverkhov P.V. , Sivovolova T.P. , Arkhipova L.M. , Grin M.A.
Publisher
New York Consultants BureauSpringer / Автономная некоммерческая организация Издательство Российской академии медицинских наук
Number of issue
4
Language
English
Pages
468-472
Status
Published
Volume
174
Year
2023
Organizations
  • 1 Peoples Friendship University of Russia
Keywords
Ehrlich carcinoma; sarcoma M-1; photodynamic therapy; photosensitizers; tumor regression
Date of creation
21.04.2023
Date of change
22.07.2024
Short link
https://repository.rudn.ru/en/records/article/record/93396/
Share

Other records

Blagonravov M.L., Kolomeichuk S.N., Korneva V.A., Kuznetsova T.Yu., Korostovtseva L.S., Bochkarev M.V., Sviryaev Yu.V.
Bulletin of Experimental Biology and Medicine. New York Consultants BureauSpringer / Автономная некоммерческая организация Издательство Российской академии медицинских наук. Vol. 174. 2023. P. 460-463